136 episódios

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

GRACEcast Lung Cancer Audio cancerGRACE - H. Jack West, MD

    • Ciência

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

    Squamous Lung Cancer Part 5, Q and A Session (audio)

    Squamous Lung Cancer Part 5, Q and A Session (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, answers audience questions about squamous lung cancer.

    • 13 min
    Squamous Lung Cancer, Part 4: Immunotherapy (audio)

    Squamous Lung Cancer, Part 4: Immunotherapy (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, describes current research in immunotherapy as treatment for squamous lung cancer.

    • 7 min
    Squamous Lung Cancer, Part 3: Treatment (audio)

    Squamous Lung Cancer, Part 3: Treatment (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, outlines treatment options for squamous lung cancer.

    • 12 min
    Squamous Lung Cancer, Part 2: Genomic Testing (audio)

    Squamous Lung Cancer, Part 2: Genomic Testing (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, discusses the importance of genomic testing in squamous lung cancer.

    • 11 min
    Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (audio)

    Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, describes the diagnosis, presentation and workup of squamous lung cancer.

    • 15 min
    ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

    ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

    Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.

    • 5 min

Top podcasts em Ciência

Ciência Sem Fim
Estúdios Flow
Naruhodo
B9, Naruhodo, Ken Fujioka, Altay de Souza
O Tempo Virou
Giovanna Nader
Ciência Suja
Ciência Suja
Sinapse
Ciência Todo Dia
Ta de Clinicagem
tadeclinicagem

Mais de GRACEcast

GRACEcast Lung Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Head and Neck Cancer Audio
cancerGRACE - H. Jack West, MD
GRACEcast Radiation Oncology Audio
cancerGRACE - H. Jack West, MD
GRACEcast ALL Subjects audio and video
cancerGRACE - H. Jack West, MD
GRACEcast Radiation Oncology Video
cancerGRACE - H. Jack West, MD
GRACEcast Head and Neck Cancer Video NEW
cancerGRACE - H. Jack West, MD